US tariffs: Global brokerage firm Citi sees minimal impact on Indian pharma firms
Mumbai- Global brokerage firm Citi said on Tuesday there is a low likelihood of the US imposing tariffs on Indian pharmaceuticals, despite ongoing discussions around the issue. The brokerage firm analysed the potential effects of a 10 per cent tariff on Indian pharmaceutical companies, particularly those with significant exposure to the US generics market.Currently, India…